Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Consultant General, Hepatobiliary Pancreatic and Liver Transplant Surgeon at Sunway Medical Centre Velocity (SMCV), Dr Johann ...

"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

The American Cancer Society expects doctors to diagnose more than two million new cases of cancer in the next 12 months. That’s about 5,600 new cases every day, and that’s ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.